EUVIMEDEUVIMED entdecken
Crossref

Inhibition of GLUT1 Ameliorates Thickening of the Glomerular Basement Membrane via the Rheb/mTORC1 Pathway in Diabetic Nephropathy

Jitu Xu, Jiaoyu Shi, Ping Hu, Nan Jiang, Jiayan Zhong, Guangze Shao, Siqi Zhu, Yue Gu, Wenyao Jia, Guozhe Cheng, Xitong Xu, Junying Liu und 7 weitere

Diabetes · 01.08.2026 · 75 (8) · 1437-1449

DOI: 10.2337/db25-0883 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, online erschienen am 08.06.2026. Verfasst von Jitu Xu und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology of Huadong Hospital, Shanghai Key Laboratory of Clinical Geriatric Medicine, Shanghai Institute of Geriatrics and Gerontolog…. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Glucose Transporter Type 1, Mechanistic Target of Rapamycin Complex 1, Ras Homolog Enriched in Brain Protein. Die Arbeit nennt 45 Literaturangaben. Gefördert von: Zhengzhou Municipal Fundamental Research and Applied Basic Research Program, Natural Science Foundation of Shanghai Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Thickening of the glomerular basement membrane (GBM) is one of the most common pathological changes in diabetic nephropathy (DN), but its underlying mechanisms remain unclear. Collagen α1(IV) is predominantly expressed by endothelial cells and upregulated in the glomeruli in DN. Glucose transporter type 1 (GLUT1) serves as the primary transporter for glucose uptake in endothelial cells. This study demonstrates that GLUT1 and collagen α1(IV) expression are both upregulated and positively correlated in glomerular endothelial cells (GECs) in DN. Inhibition of GLUT1 improved renal dysfunction and morphological abnormalities associated with DN progression in db/db mice and streptozotocin-induced diabetic rat models. Mechanistically, GLUT1 promotes collagen α1(IV) overexpression through activation of the Rheb/mTORC1 pathway in GECs. In vitro studies revealed that O-GlcNAcylation of Rheb seems to mediate GLUT1-driven Rheb upregulation and subsequent mTORC1 activation. Collectively, these data establish the GLUT1-Rheb/mTORC1–collagen α1(IV) axis in GECs, highlighting the pivotal role of GECs in mediating GBM thickening during DN pathogenesis. Article Highlights The role of glomerular endothelial cells in basement membrane collagen α1(IV) accumulation in diabetic nephropathy was previously unclear. Glucose transporter type 1 (GLUT1) expression drives collagen α1(IV) production via Rheb upregulation and mTORC1 activation. Rheb O-GlcNAcylation serves as a key modification that activates mTORC1 signaling, leading to increased collagen α1(IV) production. Pharmacological inhibition of GLUT1 mitigates diabetic nephropathy progression, highlighting its therapeutic potential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NephropathiesGlucose Transporter Type 1Mechanistic Target of Rapamycin Complex 1Ras Homolog Enriched in Brain ProteinGlomerular Basement MembraneAnimalsRatsMaleMiceSignal TransductionDiabetes Mellitus, ExperimentalEndothelial CellsCollagen Type IVRats, Sprague-Dawley

Substanzen

Glucose Transporter Type 1Mechanistic Target of Rapamycin Complex 1Ras Homolog Enriched in Brain ProteinRheb protein, mouseCollagen Type IVRheb protein, rat

Autor:innen und Institutionen

  • Department of Nephrology of Huadong Hospital, Shanghai Key Laboratory of Clinical Geriatric Medicine, Shanghai Institute of Geriatrics and Gerontology, Department of Pathology of the School of Basic Medical Sciences, Fu…
  • Institute of Nephrology, Zhong Da Hospital, Southeast University School of Medicine, Nanjing, China.
  • Department of Pathology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Department of Nephrology, Minhang Hospital, Fudan University, Shanghai, China.
  • Department of Nephrology, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • National Experimental Teaching Demonstration Center of Basic Medicine, Fudan University, Shanghai, China.

ORCID-Profile: Haidong He, Huijuan Wu

Förderung

  • Zhengzhou Municipal Fundamental Research and Applied Basic Research Program
  • Natural Science Foundation of Shanghai Municipality

Zitieren

APA

Xu, J., Shi, J., Hu, P., Jiang, N., Zhong, J., Shao, G., Zhu, S., Gu, Y., Jia, W., Cheng, G., Xu, X., Liu, J., Zhao, Z., Zhang, Z., Wang, S., Liu, J., Liu, J. J., He, H., & Wu, H. (2026). Inhibition of GLUT1 Ameliorates Thickening of the Glomerular Basement Membrane via the Rheb/mTORC1 Pathway in Diabetic Nephropathy. Diabetes, 75(8), 1437-1449. https://doi.org/10.2337/db25-0883

Vancouver

Xu J, Shi J, Hu P, Jiang N, Zhong J, Shao G, et al. Inhibition of GLUT1 Ameliorates Thickening of the Glomerular Basement Membrane via the Rheb/mTORC1 Pathway in Diabetic Nephropathy. Diabetes. 2026;75(8):1437-1449. doi:10.2337/db25-0883

BibTeX
@article{Xu2026,
  author = {Xu, Jitu and Shi, Jiaoyu and Hu, Ping and Jiang, Nan and Zhong, Jiayan and Shao, Guangze and Zhu, Siqi and Gu, Yue and Jia, Wenyao and Cheng, Guozhe and Xu, Xitong and Liu, Junying and Zhao, Zhonghua and Zhang, Zhigang and Wang, Shuyang and Liu, Jun and Liu, Jian-Jun and He, Haidong and Wu, Huijuan},
  title = {Inhibition of GLUT1 Ameliorates Thickening of the Glomerular Basement Membrane via the Rheb/mTORC1 Pathway in Diabetic Nephropathy},
  journal = {Diabetes},
  year = {2026},
  volume = {75},
  number = {8},
  pages = {1437--1449},
  doi = {10.2337/db25-0883}
}
Kostenlos starten →